Breast invasive carcinoma (BRCA) was considered as a heterogeneous disease and can be divided into four classical subtypes based on the expression of ER, PR, and HER2, namely, HER2-enriched, basal-like, Lumina A, and Lumina B (51). Here, ERBB2 is linked to invasive breast carcinoma.